Our evaluation and opinions of the EPI-321 clinical trial design and potential based on the pre-clinical data
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Our evaluation and opinions of the EPI-321 clinical trial design and potential based on the pre-clinical data
-
Narrated by:
-
By:
Summary
"But did you bleed him? - Aesculapius says that bleeding is not a cure. It is only a way of proving that you are a physician at the expense of your patient." Finally, we discuss the EPI-321 epigenetic editing phase I/II clinical trial design and its potential for answering key questions necessary for going to phase III and for providing benefit to participants and patients.
adbl_web_anon_alc_button_suppression_c
No reviews yet